Björn Cochlovius
President bij BIOCURE TECHNOLOGY INC.
Oorsprong van het eerstegraads netwerk van Björn Cochlovius
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Ruprecht-Karls-Universität Heidelberg
33
| College/University | Other Consumer Services | 33 |
| Public Company | Financial Conglomerates | 11 | |
| Public Company | Biotechnology | 5 | |
Eleva GmbH
 Eleva GmbH BiotechnologyHealth Technology Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany.
3
| Holding Company | Biotechnology | 3 |
Sapreme Technologies BV
 Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands.
2
| Holding Company | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Björn Cochlovius via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BASF SE | Electrical Products | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
| SINO BIOPHARMACEUTICAL LIMITED | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer Director/Board Member | |
BASF Antwerpen NV
 BASF Antwerpen NV Chemicals: Major DiversifiedProcess Industries BASF Antwerpen NV manufactures organic and inorganic chemicals and plastics. Its products include ammonia, sulfate, benzene, chemicals, plastics, polystyrene products, sulfide, sulfite, sulfur compounds, and sulfuric acid. The company was founded in 1964 and is headquartered in Antwerpen, Belgium. | Chemicals: Major Diversified | Corporate Officer/Principal Corporate Officer/Principal | |
| Kulturkreis Der Deutschen Wirtschaft Im Bdi E.V | Director/Board Member Corporate Officer/Principal | ||
| Innovationsforum Energiewende E.V | Director/Board Member Corporate Officer/Principal | ||
| Zukunft Metropolregion Rhein Neckar eV | Director/Board Member Chairman | ||
| Zukunftsinitiative Rheinalnd Pfalz e.V. | Chairman Chairman | ||
| Bundesarbeitgeberverband Chemie eV | President Director/Board Member | ||
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Chairman Corporate Officer/Principal | |
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Freiburg | College/University | Corporate Officer/Principal Doctorate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
Softhale NV
 Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Pharmaceuticals: Major | Chief Executive Officer Chief Investment Officer | |
The University of Oregon Investment Group
 The University of Oregon Investment Group Investment ManagersFinance The University of Oregon Investment Group (UOIG) is the state-owned investment advisor headquartered in Eugene, Oregon. Founded in 1998, UOIG provides students with the opportunity to participate in the operation of an investment management organization. The firm’s overall mission is to enhance their members’ education through learning in-depth equity research processes, valuation techniques, portfolio management, and market analysis. | Investment Managers | Analyst-Equity Analyst-Equity | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Wittenburg Center on Global Ethics
 Wittenburg Center on Global Ethics Investment Trusts/Mutual FundsMiscellaneous Wittenburg Center on Global Ethics is a thinktank that aims to promote responsible behavior in decision-making processes, leadership structures, programs, and strategies across all sectors of society. The non-profit company is based in Wittenberg, Germany. The German company believes that freedom and values are the pillars of a functioning community, and that ethical behavior is especially important in times of uncertainty and conflict. The company encourages perspective-taking and seek to find common ground in every challenge, bringing together experts from different fields and industries to promote ethical behavior. The company's clients range from international corporations to labor unions. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Pharmathen SA
 Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim (Canada) Ltd.
 Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Biotechnology | Corporate Officer/Principal | |
The Francis Crick Institute Ltd.
 The Francis Crick Institute Ltd. Medical/Nursing ServicesHealth Services The Francis Crick Institute Ltd. operates as a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. The firms works helps to understand why disease develops and to find new ways to treat, diagnose, and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. The company is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree | |
| University of Münster | College/University | Corporate Officer/Principal | |
| Technische Universität Bergakademie Freiberg | College/University | Doctorate Degree | |
Universitätsklinikum Heidelberg
 Universitätsklinikum Heidelberg Hospital/Nursing ManagementHealth Services Universitätsklinikum Heidelberg engages in the management and operation of hospitals. It offers medical services in the fields of surgery, neurology, anesthesiology, internal medicine, urology, radiology, psychiatry, orthopedics, nuclear medicine, cardiology, and oncology. The company is headquartered in Heidelberg, Germany. | Hospital/Nursing Management | Corporate Officer/Principal | |
CeloNova BioSciences, Inc.
 CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | Medical Specialties | Director/Board Member | |
TopiVert Ltd.
 TopiVert Ltd. BiotechnologyHealth Technology TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Seroba BioVentures Ltd.
 Seroba BioVentures Ltd. Investment ManagersFinance Seroba BioVentures Ltd (Seroba BioVentures) is a venture capital subsidiary of Kernel Management Partners Ltd founded in 2001 by Peter Sandys and Seamus O''Hara. The firm is headquartered in Dublin, Ireland. | Investment Managers | Private Equity Investor | |
PHion Therapeutics Ltd.
 PHion Therapeutics Ltd. BiotechnologyHealth Technology PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom. | Biotechnology | Director/Board Member | |
| AURIC PACIFIC GROUP LIMITED | Food: Major Diversified | Chief Executive Officer | |
| National University of Singapore | College/University | Masters Business Admin | |
| PT MATAHARI DEPARTMENT STORE TBK | Department Stores | Chairman | |
Medovent GmbH
 Medovent GmbH Medical SpecialtiesHealth Technology Medovent GmbH engages in the development and manufacture of medical devices made of the biopolymer chitosan. Its main products are a nerve guide used for peripheral nerve injuries and a direct suture for short nerve defects. The company was founded by Rivelino Montenegro and Thomas Freier in 2006 and is headquartered in Mainz, Germany. | Medical Specialties | Director/Board Member | |
| University of the Witwatersrand | College/University | Graduate Degree | |
| Rhodes University | College/University | Undergraduate Degree | |
Pharmathen International SA
 Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Pharmaceuticals: Major | Director/Board Member | |
| Eberhard Karls Universität Tübingen | College/University | Corporate Officer/Principal | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium. | Pharmaceuticals: Major | Chairman | |
| MERUS N.V. | Biotechnology | Director/Board Member | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal |
Statistieken
Internationaal
| Duitsland | 16 |
| Zweden | 10 |
| Verenigd Koninkrijk | 8 |
| België | 4 |
| Verenigde Staten | 4 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 260 |
| Corporate Officer/Principal | 123 |
| Chairman | 60 |
| Independent Dir/Board Member | 49 |
| Director of Finance/CFO | 39 |
Sterkste connecties
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Konstantin Lichtenwald | 50 |
| Ping Tse | 43 |
| Per Gunnar Ernst Aniansson | 31 |
| Hans Lennart Rudolf Wigzell | 30 |
| Margret Suckale | 26 |
| Mohsen M. Sohi | 25 |
| Michael Heinz | 23 |
| Jeanne Bolger | 20 |
| Anna Lefevre Skjöldebrand | 17 |
| Erich Schlick | 15 |
| Vincenzo Cariello | 14 |
| Thorlef Spickschen | 14 |
| Andre Hoekema | 14 |
| Fredrik Järrsten | 12 |
- Beurs
- Insiders
- Björn Cochlovius
- Bedrijfsconnecties
